“This is a big win for cannabis,” writes MarketWatch columnist Nigan Arora. This drug has potential to generate over $1 billion in sales by 2022; GW Pharmaceuticals has already had a run based on the news, but there's still upside, writes Arora. Moreover the company, which also has a pipeline of other ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment